DexCom Inc (DXCM)
Current ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total current assets | US$ in thousands | 4,425,900 | 4,698,400 | 5,002,900 | 3,767,400 | 3,668,800 | 3,398,500 | 3,808,700 | 3,746,600 | 3,684,400 | 3,656,200 | 3,474,200 | 3,445,100 | 3,424,800 | 3,237,100 | 3,033,000 | 1,995,700 | 1,969,400 | 1,815,700 | 1,744,200 | 1,690,800 |
Total current liabilities | US$ in thousands | 1,556,000 | 1,678,600 | 2,069,700 | 1,865,000 | 1,839,300 | 900,500 | 807,000 | 711,400 | 720,800 | 734,900 | 600,700 | 604,100 | 614,100 | 506,400 | 400,100 | 342,800 | 360,200 | 322,400 | 288,200 | 235,400 |
Current ratio | 2.84 | 2.80 | 2.42 | 2.02 | 1.99 | 3.77 | 4.72 | 5.27 | 5.11 | 4.98 | 5.78 | 5.70 | 5.58 | 6.39 | 7.58 | 5.82 | 5.47 | 5.63 | 6.05 | 7.18 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $4,425,900K ÷ $1,556,000K
= 2.84
The current ratio of Dexcom Inc has shown fluctuations over the past eight quarters, ranging from a low of 1.99 in Q4 2022 to a high of 5.27 in Q1 2022. The current ratio measures the company's ability to meet its short-term obligations with its current assets.
In recent quarters, Dexcom Inc has maintained a relatively healthy current ratio, indicating a strong ability to cover its short-term liabilities with its current assets. The current ratio has generally been above 2, which is considered a good benchmark for most industries.
However, there was a decline in the current ratio from Q2 2023 to Q4 2023, which may raise concerns about the company's liquidity position in the short term. It is important for investors and stakeholders to monitor the trend in the current ratio over time to assess Dexcom Inc's ability to manage its short-term financial obligations effectively.
Peer comparison
Dec 31, 2023